- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Chronic disease management startup Phablecare raises Rs 187 crore in funding round led by Kalaari Capital
The company is looking at acquiring other players in fray to consolidate its position, and has allocated capital and secured debt funding for the same, the statement said.
Mumbai: Phablecare, a chronic disease management startup, on Monday said it has raised Rs 187 crore in a funding round led by Kalaari Capital. Aflac Ventures, Digital Horizon and Stride Ventures also participated in the round along with existing investors Omron Ventures, SOSV, Social Starts, and Fresco Capital.The funds raised, which comes within a year of a similar exercise, will be deployed...
Mumbai: Phablecare, a chronic disease management startup, on Monday said it has raised Rs 187 crore in a funding round led by Kalaari Capital. Aflac Ventures, Digital Horizon and Stride Ventures also participated in the round along with existing investors Omron Ventures, SOSV, Social Starts, and Fresco Capital.
Read also: Govt grants Rs 24 crore to Epygen Biotech to begin cost-effective COVID vaccine trials
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751